www.rupeedesk.in
Stocks of major pharmaceutical companies are seen moving sideways to negative next
week due to out-performance of mainstream sectors such as Auto, Banking,
Infrastructure, Metals, and Energy. The 50-stock Nifty is expected to touch 6,700 levels
in the next week led by these stocks. The positive momentum that pharma stocks showed
in the last few months is nearing its end now. Now as the other sectors such as Banking,
Auto are seen picking up, the Pharma stocks, being defensive, are not expected to gain as
much.
Among the major pharmaceutical stocks, stocks of Lupin Ltd are expected to outperform
next week. If the stock (Lupin) closes above 1,000 rupees, its out-performance might
continue. Ranbaxy Laboratories Ltd's stocks to show positive performance next week.
For Aurobindo Pharma Ltd, the stocks could form a good downward move if they close
below 480 rupees. Yesterday, the company's stocks ended nearly 5% down at 506.45
rupees on the National Stock Exchange.
Stocks of major pharmaceutical companies are seen moving sideways to negative next
week due to out-performance of mainstream sectors such as Auto, Banking,
Infrastructure, Metals, and Energy. The 50-stock Nifty is expected to touch 6,700 levels
in the next week led by these stocks. The positive momentum that pharma stocks showed
in the last few months is nearing its end now. Now as the other sectors such as Banking,
Auto are seen picking up, the Pharma stocks, being defensive, are not expected to gain as
much.
Among the major pharmaceutical stocks, stocks of Lupin Ltd are expected to outperform
next week. If the stock (Lupin) closes above 1,000 rupees, its out-performance might
continue. Ranbaxy Laboratories Ltd's stocks to show positive performance next week.
For Aurobindo Pharma Ltd, the stocks could form a good downward move if they close
below 480 rupees. Yesterday, the company's stocks ended nearly 5% down at 506.45
rupees on the National Stock Exchange.
